Shuzhen Tan

792 citations
9 papers · 586 indexed · 1 hit paper · h-index 6
Topics
RNA modifications and cancer (5 papers)Cancer-related molecular mechanisms research (4 papers)Cancer-related gene regulation (2 papers)
Partner nations
China

In The Last Decade

Shuzhen Tan

9 papers receiving 579 citations

Hit Papers

Cancer immunotherapy: Pros, cons and beyond20202026202220242020100200300400500

Peers

Shuzhen Tan
Comparison fields: 5 of 77
  • Molecular Biology 250
  • Oncology 239
  • Immunology 182
  • Biomedical Engineering 138
  • Cancer Research 107
Replace Neha Papneja with:
Neha Papneja Canada
Jingyao Tu China
Alyssa Vito Canada
Abhijit Aithal United States
Jenny Sprooten Belgium
Nader El-Sayes Canada
Xiaoli Wei China
Roberto Ruiu Italy
David J. Zahavi United States
Shuzhen Tan relative to Neha Papneja Canada Neha Papneja's profile →
Citations per field
00.5×1.5×
Neha Papneja · 1×
Citations per year

Countries citing papers authored by Shuzhen Tan

Since Specialization
Citations

This map shows the geographic impact of Shuzhen Tan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuzhen Tan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuzhen Tan more than expected).

Fields of papers citing papers by Shuzhen Tan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shuzhen Tan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuzhen Tan. The network helps show where Shuzhen Tan may publish in the future.

Co-authorship network of co-authors of Shuzhen Tan

This figure shows the co-authorship network connecting the top 25 collaborators of Shuzhen Tan. A scholar is included among the top collaborators of Shuzhen Tan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shuzhen Tan. Shuzhen Tan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
#WorkIndexed citations
1 9
2 4
3 21
4 1
5 8
6 25
7
Cancer immunotherapy: Pros, cons and beyondbreakdown →
501
8
Methylation of p16 and p15 genes in multiple myeloma.
15
9
Inactivation of p16 gene in leukemia.
2

About Shuzhen Tan

Shuzhen Tan is a scholar working on Cancer Research, Otorhinolaryngology and Emergency Medicine, having authored 9 papers that have together received 586 indexed citations. Recurring topics across this work include RNA modifications and cancer (5 papers), Cancer-related molecular mechanisms research (4 papers) and Cancer-related gene regulation (2 papers). The work is most often cited by research in Oncology (239 citations), Immunology (182 citations) and Cancer Research (107 citations). Shuzhen Tan has collaborated with scholars based in China. Frequent co-authors include Xiao Zhu, Dongpei Li, Xiangsheng Zhang, Kai Li, Zhilin Zou, Guosheng Liang, Yin Wu, Jingzhong Liu, Yongmei Huang and Shu‐Guang Zhou. Their work appears in journals such as Biomedicine & Pharmacotherapy, BMJ Open and Frontiers in Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026